- Home
- HTH vs NEO Comparison
HTH vs NEO Comparison
Compare HTH & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- NEO
- Stock Information
- Founded
- HTH 1998
- NEO 2001
- Country
- HTH United States
- NEO United States
- Employees
- HTH N/A
- NEO N/A
- Industry
- HTH Major Banks
- NEO Precision Instruments
- Sector
- HTH Finance
- NEO Health Care
- Exchange
- HTH Nasdaq
- NEO Nasdaq
- Market Cap
- HTH 2.1B
- NEO 2.3B
- IPO Year
- HTH 2004
- NEO 1999
- Fundamental
- Price
- HTH $31.28
- NEO $17.47
- Analyst Decision
- HTH Hold
- NEO Strong Buy
- Analyst Count
- HTH 3
- NEO 10
- Target Price
- HTH $34.50
- NEO $20.30
- AVG Volume (30 Days)
- HTH 230.1K
- NEO 553.2K
- Earning Date
- HTH 01-23-2025
- NEO 11-05-2024
- Dividend Yield
- HTH 2.18%
- NEO N/A
- EPS Growth
- HTH N/A
- NEO N/A
- EPS
- HTH 1.63
- NEO N/A
- Revenue
- HTH $1,169,826,000.00
- NEO $644,118,000.00
- Revenue This Year
- HTH N/A
- NEO $12.98
- Revenue Next Year
- HTH $0.79
- NEO $9.83
- P/E Ratio
- HTH $19.13
- NEO N/A
- Revenue Growth
- HTH N/A
- NEO 12.06
- 52 Week Low
- HTH $28.58
- NEO $12.77
- 52 Week High
- HTH $35.66
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- HTH 44.12
- NEO 57.54
- Support Level
- HTH $31.01
- NEO $17.24
- Resistance Level
- HTH $32.04
- NEO $18.20
- Average True Range (ATR)
- HTH 0.61
- NEO 0.61
- MACD
- HTH -0.08
- NEO -0.11
- Stochastic Oscillator
- HTH 10.83
- NEO 24.04
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. Its primary line of business is to provide business and consumer banking services from offices throughout Texas through the PlainsCapital Bank. The company also provides other financial products and services through its broker-dealer and mortgage origination segments. The company generates a majority of its revenue through its banking operations.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.